[pending] LUBRICANT EYE DROPS SOLUTION (POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL)
Pending LLM rewrite. Source: FDA_DRUG D-0407-2025.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Pending LLM scoring against the rubric.
Plain-English summary
cGMP deviations and lack of assurance of sterility.
The recalled product
- Product
- LUBRICANT EYE DROPS SOLUTION (POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL)
- Brand
- LUBRICANT EYE DROPS SOLUTION
- Manufacturer
- BRS Analytical Services, LLC
- Category
- Drug — Drugs
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot
- expiry: Lot 117
- exp 9/20/25
- Lot 118
- exp 9/25/25
- Lot 119
- exp 9/27/25
- Lot 121
- exp 10/05/25
- Lot 161
- exp 5/01/26
- Lot 171
- exp 6/18/26
- Lot 172
- exp 6/24/26
- Lot 174
- exp 7/01/26
- Lot 175
- exp 7/08/26
- Lot 200
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27